TASP0390325是一种高亲和力、口服有效的精氨酸加压素1B受体(V1BR)拮抗剂，具有抗抑郁与抗焦虑活性。

/

-25~-15℃避光保存，有效期3年。

[1] Iijima M, Yoshimizu T, Shimazaki T, Tokugawa K, Fukumoto K, Kurosu S, Kuwada T, Sekiguchi Y, Chaki S. Antidepressant and anxiolytic profiles of newly synthesized arginine vasopressin V1B receptor antagonists: TASP0233278 and TASP0390325. Br J Pharmacol. 2014 Jul;171(14):3511-25. doi: 10.1111/bph.12699. PMID: 24654684; PMCID: PMC4105937.[2]Koga K, Nagai Y, Hanyu M, Yoshinaga M, Chaki S, Ohtake N, Ozaki S, Zhang MR, Suhara T, Higuchi M. High-Contrast PET Imaging of Vasopressin V1B Receptors with a Novel Radioligand, 11C-TASP699. J Nucl Med. 2017 Oct;58(10):1652-1658. doi: 10.2967/jnumed.116.188698. Epub 2017 Apr 27. PMID: 28450560.